ART for Advanced Training
Module description
Chapter index
Faculty
Faculty disclosure
Practice sessions
Back to modules

Module description

The goal of this program is to provide physicians and practitioners working or interested in Reproductive Medicine with the most advanced aspects of assisted reproductive techniques (ARTs). After a brief review of the different types of medications available to induce multiple follicular development and the factors involved in choosing a particular protocol, the course will explain the different protocols available for the various diagnosis of infertility. This is followed by details on follicular monitoring, oocyte retrieval, oocyte/embryo quality assessment and embryo transfer techniques. The course will also address the topic of third party reproduction, i.e. use of oocyte donors and use of gestational carriers, and the topic of pre-implantation genetic screening (PGS) and pre-implantation genetic diagnosis (PGD). Risks and complications deriving from ARTs will also be reviewed.

Learning objectives:

Upon completion of this program, the participant will be able to:

  • Describe the various medications available for inducing multiple follicular developments for patients requiring IVF.
  • Identify the most important deciding factors and the impact of different etiologies of infertility to select a protocol for ART.
  • Discuss the methods to monitor follicular development, the timing for oocyte retrieval and the assessment of oocyte/embryo quality.
  • Recognize the field of application of PGS or PGD and when to recommend third party reproduction (oocyte donation or gestational carrier).
  • Discuss the risks associated with the use of advanced reproductive techniques.
  • Formulate a strategy to counsel patients with repetitive failures of pregnancy.

Target audience:

This module is intended for gynecologists, reproductive endocrinologists, embryologists and researchers working in the field of reproductive medicine and infertility.

CME accreditation:

This module will be submitted for CME Accreditation from the European Accreditation Council for Continuing Medical Education (EACCME). This course may include data on investigational uses of drugs and other treatments not approved by EMEA, FDA and other National or International Health Authorities in the indications mentioned.

Please, contact us regarding the CME credits for this module.